Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jeffrey H, King"'
Autor:
R. Steven Tharratt, Dean Williamson, Richard H. White, Ron C Regalia, Robert C. Gosselin, Jeffrey H. King, William E. Dager, Timothy E Albertson
Publikováno v:
Pharmacotherapy. 26:1091-1098
Study Objective. To assess the effectiveness of using low-dose recombinant activated factor VII (rFVIIa) to reverse the effects of warfarin in critically ill patients with major bleeding events. Design. Prospective observational study. Setting. Inten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af94e8772c374a988049f25d35a4b7b4
https://doi.org/10.1592/phco.26.8.1091
https://doi.org/10.1592/phco.26.8.1091
Autor:
William E. Dager, Jeffrey H. King
Publikováno v:
Annals of Pharmacotherapy. 40:9-14
Background: Data are limited on aminoglycoside pharmacokinetic differences between acute renal failure (ARF) and chronic kidney disease (CKD) or infection survival when maintaining peak and pre-hemodialysis serum concentrations between 7 and 10 and 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c93d62aa6e445569784f385efa06cf66
https://doi.org/10.1345/aph.1g064
https://doi.org/10.1345/aph.1g064
Autor:
Patti Y Togioka, Richard H. White, William E Dager, Jennifer M Branch, Sandy Pak, Ruby E Ferrer, Stacey L Chow, Jeffrey H. King
Publikováno v:
Annals of Pharmacotherapy. 39:1182-1187
BACKGROUND The low-molecular-weight heparins (LMWHs) have been shown to be effective in the outpatient treatment of deep vein thrombosis (DVT). Data regarding outpatient use of any LMWH in pulmonary embolism (PE) or tinzaparin in DVT while transition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caafbb92db723b72447aa1931daeffd1
https://doi.org/10.1345/aph.1e677
https://doi.org/10.1345/aph.1e677
Autor:
Robert C, Gosselin, Jeffrey H, King, Kim A, Janatpur, William H, Dager, Edward C, Larkin, John T, Owings
Publikováno v:
Archives of Pathology & Laboratory Medicine. 128:1142-1145
Context.—Direct thrombin inhibitors (DTIs) and fondaparinux represent a new class of anticoagulants. The effects of DTIs on activated partial thromboplastin time and prothrombin time measurements have been reported previously, but there are limited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::391ebbdaf5b90d87f814a8f1518c423f
https://doi.org/10.5858/2004-128-1142-eopfad
https://doi.org/10.5858/2004-128-1142-eopfad
Autor:
John T. Owings, William E. Dager, Jeffrey H. King, Edward C. Larkin, Kim A. Janatpour, Robert C. Gosselin
Publikováno v:
Annals of Pharmacotherapy. 38:1383-1388
BACKGROUND: Patients with heparin-induced thrombocytopenia and thrombosis may be acutely anticoagulated with direct thrombin inhibitors (DTIs). The anticoagulation is typically monitored using the activated partial thromboplastin time (aPTT) or ecari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5dc354d66f2511d1f8c43b5b9b6cda9
https://doi.org/10.1345/aph.1d565
https://doi.org/10.1345/aph.1d565
Autor:
Robert C. Gosselin, William E. Dager, Jeffrey H. King, Kim Janatpour, Kathleen Mahackian, Edward C. Larkin, John T. Owings
Publikováno v:
American Journal of Clinical Pathology. 121:593-599
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5adf447d1859d5dee2e850926a08a698
https://doi.org/10.1309/d79k4yg78ntnyy38
https://doi.org/10.1309/d79k4yg78ntnyy38
Autor:
Teresa L. Iglesias, Carolyn J. VanCouwenberghe, Kalen L. Jacobson, Stuart H. Cohen, William Lippert, John F. Inciardi, Jeffrey H. King
Publikováno v:
Clinical Infectious Diseases. 21:1107-1113
Gram-negative pathogens are increasingly resistant to extended-spectrum cephalosporins (ESCs). Using a prospective, case-controlled observational study, we examined the prevalence and the risk factors for development of resistance to ESCs in group I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8a1fa4d569dfea769a17f2629cfb12c
https://doi.org/10.1093/clinids/21.5.1107
https://doi.org/10.1093/clinids/21.5.1107
Autor:
Hien H. Nguyen, Stuart H. Cohen, Jeffrey H. King, Neil M. Flynn, Caroline Monchaud, Hsin Huang
Publikováno v:
Diagnostic microbiology and infectious disease. 60(4)
To demonstrate that injecting drug use is a major risk factor of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infection and injecting drug users may be a reservoir of CA-MRSA infection in our community, we conducted a ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c8cc9ae1ae8be38e07c9fa61209f763
https://pubmed.ncbi.nlm.nih.gov/18178362
https://pubmed.ncbi.nlm.nih.gov/18178362
Autor:
Neil M. Flynn, Hsin Huang, Stuart H. Cohen, Margaret Morita, Caroline Monchaud, Jeffrey H. King
Publikováno v:
Journal of clinical microbiology. 44(7)
Methicillin-resistant Staphylococcus aureus (MRSA) has long been a common pathogen in healthcare facilities, but in the past decade, it has emerged as a problematic pathogen in the community setting as well. A retrospective case series study of patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64c983b381cf2c5e716991d35cae7fb1
https://pubmed.ncbi.nlm.nih.gov/16825359
https://pubmed.ncbi.nlm.nih.gov/16825359
Autor:
Robert C, Gosselin, William E, Dager, Jeffrey H, King, Kim, Janatpour, Kathleen, Mahackian, Edward C, Larkin, John T, Owings
Publikováno v:
American journal of clinical pathology. 121(4)
Direct thrombin inhibitors (DTIs) represent a new class of promising anticoagulation agents. The DTIs frequently are used to provide initial anticoagulation, with long-term therapy requiring eventual transition to coumarins. Unfortunately, DTIs not o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::89771b61451122cd8cd43e29bf49069b
https://pubmed.ncbi.nlm.nih.gov/15080313
https://pubmed.ncbi.nlm.nih.gov/15080313